RS Research is a clinically-validated biotech company developing targeted oncology therapies using Sagitta® drug-delivery platforms, disrupting the efficacy-toxicity trade-off.
Geliştirme adımları ülkemizde atılarak klinik araştırmayla hastalara ulaşan Türkiye’nin ilk özgün ilaç adayı RS-0139’un solid tümörlerde yürütülen klinik araştırması tamamlandı.
Cover Story – The Business Leaders of Science: Smart fight against cancer
RS Research, a clinically-validated biotechnology company developing targeted oncology therapies with a focus on improved safety and efficacy, announced that an abstract presenting the Phase 1a clinical trial results of its lead candidate, RS_0139, has been accepted for online publication at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL. […]
Phase 1a dose-escalation study of RS-0139: A novel tumor-targeted nanomedicine for advanced solid tumors. ASCO 2025, Chicago Authors Ozturk Ates1, Gulsah Nomak2, Hakan Orer3, Recep Selim Şentürk4, Fevzi Altuntas1, Hamdi Sena Nomak5, Rana Sanyal2 Organizations 1Dr Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, Health Sciences University, Ankara, Turkey 2RS Research, Istanbul, Turkey 3Koc University, […]
RS Research was listed in among the most successful startups in Forbes’ 2025 Startup 50!
RS Research was listed 13th in Fast Company’s 50 Most Innovative Companies 2024
“Women Innovators” Prize in the leading category of the European Prize for Women Innovators program was awarded to RS Research Co-Founder Prof. Rana Sanyal for her successful work in the field of biotechnology. […]
RS Research has been selected to join the inaugural cohort of prestigious Turcorn100 Program
Para: 60 Amazing Women: Women in Science in Türkiye
RS Research is a clinically-validated biotech company developing targeted oncology therapies using Sagitta® drug-delivery platforms, disrupting the efficacy-toxicity trade-off.
We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or to help us customize our website for visitors in order to enhance their experience.
All informations which are collected by this way are anonymous.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts and Google Maps. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings: